Shinil Pharmaceutical신일제약
012790 · KOSDAQ · ₩012790 · 신일제약
- Market cap
- ₩76B
- Enterprise value
- ₩36B
- P/E
- 15.3×
- P/B
- 0.5×
- Dividend yield
- 3.0%
- ROE
- 3.2%
- Net margin
- 5.7%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−7.0% from the high
₩4,820Today: ₩6,260 – ₩6,400₩6,820
Returns
- 1W−0.3%
- 1M+3.6%
- 3M+27.2%
- 6M+0.6%
- YTD+4.4%
- 1Y+4.3%
- Volume today
- 11,459
- 0.5× the 20-day average
- Traded today
- ₩72M
- Listed shares
- 11,986,415
- EPS (12 months)
- ₩416
- Earnings yield 6.6%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 36 of 100 (50 is a normal day for this stock).
- MomentumFlat3.6% over the last month; the price is below its 20-day average.
- News impactLow1 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
Shinil Pharmaceutical stock overview
Shinil Pharmaceutical (신일제약, KRX: 012790) is listed on KOSDAQ, in the Biotech & Pharma sector. The company, founded in 1971, manufactures and sells pharmaceuticals, supplying products such as tablets, capsules, syrups, ointments and creams, injectables, plasters and patches to medical institutions. Its shares closed at ₩6,340 on Oct 28, 2026, up 0.32% on the day, giving it a market value of ₩76B.
Key facts
- Market cap
- ₩76B
- Sector
- Biotech & Pharma
- Latest price change
- +0.32%
- As of
- Oct 28, 2026
- Main business
- The company, founded in 1971, manufactures and sells pharmaceuticals, supplying products such as tablets, capsules, syrups, ointments and creams, injectables, plasters and patches to medical institutions.
Quick answers about Shinil Pharmaceutical
- What does Shinil Pharmaceutical do?
- The company, founded in 1971, manufactures and sells pharmaceuticals, supplying products such as tablets, capsules, syrups, ointments and creams, injectables, plasters and patches to medical institutions. It also performs contract manufacturing (CMO) for other pharmaceutical companies, and through its integrated cosmetics and health functional food brand Pharmtree, it operates in functional cosmetics, health functional foods, and quasi-drugs.
- What is the market cap of Shinil Pharmaceutical?
- The market capitalisation of Shinil Pharmaceutical was ₩76B at the close on Oct 28, 2026.
- Who are the largest shareholders of Shinil Pharmaceutical?
- According to the latest official filings, the largest reported holders are National Pension Service (0.39%, as of Dec 31, 2017); Park Jong-chang (0.21%, as of Jun 4, 2026); EMERGING MARKETS CORE EQUITY 2 PORTFOLIO (0.11%, as of Jul 31, 2026).
- When is the next earnings report from Shinil Pharmaceutical?
- Korean companies rarely announce results dates in advance. Based on when Shinil Pharmaceutical filed the same report in past years, its next 3q results is expected between Nov 13, 2026 and Nov 14, 2026.
- Does the National Pension Service own Shinil Pharmaceutical?
- Yes. The National Pension Service held 0.39% of Shinil Pharmaceutical shares as of Dec 31, 2017.
Company profile
The company, founded in 1971, manufactures and sells pharmaceuticals, supplying products such as tablets, capsules, syrups, ointments and creams, injectables, plasters and patches to medical institutions. It also performs contract manufacturing (CMO) for other pharmaceutical companies, and through its integrated cosmetics and health functional food brand Pharmtree, it operates in functional cosmetics, health functional foods, and quasi-drugs.
Written by AI from the company's latest annual report.
- Korean name
- 신일제약
- Sector
- Biotech & Pharma
- Themes
- Pharmaceuticals
- CEO
- 홍재현
- Founded
- Dec 1977
- Listed
- Aug 1999
- Listed shares
- 11,986,415
- Fiscal year ends
- Month 12
- Website
- www.sinilpharm.com
Similar companies
- Samsung Biologics207940 · ₩64T₩1,372,000−0.15%
- Celltrion068270 · ₩44T₩189,800+0.64%
- Alteogen196170 · ₩16T₩223,000+2.06%
- SK biopharmaceuticals326030 · ₩5.9T₩75,200+0.40%
- Yuhan000100 · ₩5.7T₩77,300−3.38%
- HLB028300 · ₩5.4T₩40,650+1.88%
- Hanmi Pharm128940 · ₩4.7T₩369,500+5.42%
- SAM Chun Dang Pharm000250 · ₩4.5T₩190,000+1.28%
Recent filings
See all- Corporate value-up planOct 22, 2026
- Half-year report (Jun 2026)Aug 14, 2026
- Insider shareholding reportJun 4, 2026
- Quarterly report (Mar 2026)May 15, 2026
- Amended: Annual general meeting resultsMar 26, 2026
Titles in Korean until English translations are added.
Also known as: Shinil Pharmaceutical / 신일제약 / 012790 / KRX:012790
Source: KRX statistical information